![[Symposium] 2023 Neuroscience Symposium- Neurodrug Development、Student Rendezvous (12/12 09:00~12:00、12/13 10:00~12:00)](https://nrc.tmu.edu.tw/en/wp-content/uploads/2021/05/cropped-banner-new3.jpg)
![[Symposium] 2023 Neuroscience Symposium- Neurodrug Development、Student Rendezvous (12/12 09:00~12:00、12/13 10:00~12:00)](https://nrc.tmu.edu.tw/en/wp-content/uploads/2023/12/20231212-poster-578x280.png)
We are honored to invite Prof. Mikko Airavaara and Prof. Tomi Rantamäki from the Faculty of Pharmacy at the University of Helsinki to join our 2023 Neuroscience Symposium at Taipei Medical University. The agenda of the symposium is attached. The following day, there will be a student discussion session with both professors. We warmly welcome all faculty members, colleagues, and students to actively participate in these events.
2023 Neuroscience Symposium- Neurodrug Development
Time & Date: 9:00-12:00, December 12, 2023
Venue: Classroom 9702, 7F, Biomedical and Technology Building, Shuangho Campus, Taipei Medical University
| Time | Topic | Speaker | Moderator |
| 08:45~09:00 | Registration | ||
| 09:00~09:10 | Opening Remark | Shiow-Lin Pan (潘秀玲), PhD Dean, College of Medical Science and Technology, Taipei Medical University (TMU) Yung-Hsiao Chiang (蔣永孝), MD, PhD Director, Neuroscience Research Center, TMU Superintendent, Taipei Neuroscience Institute | |
| 09:10~09:20 | Group photo | ||
| 09:20~09:35 | Introduction to the Faculty of Pharmacy, University of Helsinki | Mikko Airavaara, PhD Vice Dean for research and innovation affairs, Faculty of Pharmacy, University of Helsinki (UH) Professor, Division of Pharmacology and Pharmacotherapy, Faculty of Pharmacy, UH | |
| 09:35~09:50 | Introduction to the College of Medical Science and Technology, Taipei Medical University | Wei-Chun HuangFu (皇甫維君), PhD Vice Dean, College of Medical Science and Technology, TMU Associate Professor, Graduate Institute of Cancer Biology and Drug Discovery, TMU | |
| 09:50~10:10 | Tea Break | ||
| 10:10~10:30 | Development of biomarkers and new outcome measures for stroke: linking preclinical and clinical studies | Mikko Airavaara, PhD Vice Dean for research and innovation affairs, Faculty of Pharmacy, UH Professor, Division of Pharmacology and Pharmacotherapy, Faculty of Pharmacy, UH | Szu-Yi Chou (周思怡), PhD Professor, Ph.D. Program in Medical Neuroscience, TMU |
| 10:30~10:50 | Intelligent drug design platform for the discovery and optimization of novel kinase inhibitors | Wei-Chun HuangFu (皇甫維君), PhD Vice Dean, College of Medical Science and Technology, TMU Associate Professor, Graduate Institute of Cancer Biology and Drug Discovery, TMU | |
| 10:50~11:10 | Antidepressant mechanisms of ketamine (and other clinically used anaesthetics) | Tomi Rantamäki, PhD Professor, Division of Pharmacology and Pharmacotherapy, Faculty of Pharmacy, UH | Jia-Yi Wang (王家儀), PhD Chief Executive Officer (CEO), Neuroscience Research Center, TMU |
| 11:10~11:30 | Sp1 function in spinal motor axon guidance | Tzu-Jen Kao (高祖仁), PhD Professor, International Master Program in Medical Neuroscience, TMU | |
| 11:30~11:50 | Discussion | ||
| 11:50~12:00 | Closing Remark | ||